CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Manufactured by
United States
IntelliGenome develops diagnostic technology for serious health challenges with a vision to create a diagnostic platform that transforms the lives of people impacted by infectious disease. The company has developed and validated ultra-sensitive CRISPR-based detection of low abundance nucleic acid in small volume blood samples.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
PlexBio Co., Ltd.
Taiwan · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 2 relevant products
Biopsense Oy
Finland · 1 relevant product
Qassay
United States · 1 relevant product
Atila BioSystems
United States · 1 relevant product
Suzhou Molarray Co., Ltd.
China · 1 relevant product
Applied Biocode, Inc.
United States · 1 relevant product
Pilot Gene Technology (Hangzhou) Co., Ltd.
China · 1 relevant product
iPASY Technologies Kft
Hungary · 1 relevant product
Saygen Genetics
United Arab Emirates · 1 relevant product
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
PlexBio Co., Ltd. · Taiwan
Comprehensive collection of molecular diagnostic assays for cancer detection and analysis. Includes advanced testing solutions for lung cancer and other oncological applications.
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
Atila BioSystems · United States
A molecular assay designed for cervical cancer screening applications utilizing Atila BioSystems nucleic acid amplification chemistry.
Suzhou Molarray Co., Ltd. · China
A molecular assay for the detection of specific genetic sequences or mutations in patient samples. The test is used in genetic screening, disease diagnosis, and personalized medicine applications.
Applied Biocode, Inc. · United States
Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.
Pilot Gene Technology (Hangzhou) Co., Ltd. · China
Digital PCR-based assay for detecting single-copy genes and rare mutations in clinical samples. Provides absolute quantification without standard curve requirements.
iPASY Technologies Kft · Hungary
Diagnostic assay utilizing recombinant antibody technology to evaluate prostate cancer risk and aggressiveness from non-invasive urine samples. Designed for simplicity of operation and cost-effective accessibility in resource-limited settings.
Saygen Genetics · United Arab Emirates
Comprehensive portfolio of advanced molecular diagnostic assays supporting human healthcare applications. These assays integrate cutting-edge science with practical laboratory applications for enhanced accuracy and reliability.
GeneCker Co., Ltd. · South Korea
CRISPincette MultiCancer is an in vitro diagnostic test utilizing ultra-precision CRISPR/Cas9 technology for liquid biopsy-based cancer detection. The assay selectively cleaves wild-type DNA while amplifying target mutant sequences, enabling sensitive identification of circulating tumor DNA across multiple cancer types.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products